Login / Signup

Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy.

Paul M RidkerNader RifaiJean MacFadyenRobert J GlynnLixia JiaoPhillippe Gabriel StegMichael MillerEliot A BrintonTerry A JacobsonJean Claude TardifChristie M BallantyneR Preston MasonDeepak L Bhatt
Published in: Circulation (2022)
gov; Unique identifier: NCT01492361.
Keyphrases
  • low density lipoprotein
  • double blind
  • open label
  • phase iii
  • phase ii
  • placebo controlled
  • clinical trial
  • fatty acid
  • ionic liquid